A Clinical Trial to Evaluate the Efficacy and Safety of Anotinib Hydrochloride Capsule Combined With Epirubicin Hydrochloride Versus Placebo Combined With Epirubicin Hydrochloride in First-line Treatment of Advanced Soft Tissue Sarcoma

Clinical trial NCT05121350 · UNKNOWN

Trial details

NCT number: NCT05121350
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Soft Tissue Sarcoma

Start date: 2022-03-01
Primary completion: 2024-06-01
Enrollment: 256

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.